UnitedHealth Group Incorporated (NYSE:UNH) CAO Thomas E. Roos Sells 2,851 Shares

UnitedHealth Group Incorporated (NYSE:UNH) CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

UnitedHealth Group Trading Up 0.2 %

UNH opened at $565.33 on Monday. The business has a 50 day moving average of $504.56 and a 200-day moving average of $500.44. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market cap of $520.32 billion, a PE ratio of 34.56, a PEG ratio of 1.66 and a beta of 0.60. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $581.50.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the business earned $6.14 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. UnitedHealth Group’s payout ratio is presently 51.34%.

Hedge Funds Weigh In On UnitedHealth Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the fourth quarter worth about $26,000. CGC Financial Services LLC raised its holdings in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $31,000. Delos Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. Finally, Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the 2nd quarter worth about $31,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the stock. HSBC boosted their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, July 17th. Truist Financial boosted their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Argus lifted their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Royal Bank of Canada raised their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.